Amicus Therapeutics – Corporate Giving | Support for Rare Disease Organizations, Patient Advocacy & Community Impact

2 Min Read

Organization: Amicus Therapeutics

About the Funder

Amicus Therapeutics is a global biotechnology company focused on developing therapies for people living with rare diseases. As part of its commitment to the rare disease community, Amicus provides corporate giving support to nonprofit organizations advancing patient advocacy, education, community programs, and improved quality of life for individuals and families affected by rare disease.

Their giving aligns closely with the company’s mission: to deliver meaningful benefits to patients through science, service, and compassion.

What This Program Funds

Amicus provides charitable contributions to organizations that directly support people living with rare diseases.
Funding may support:

1. Patient Advocacy & Community Support Programs

Rare disease awareness initiatives
Patient and caregiver resources
Support groups, workshops, and community-building events

2. Education & Outreach

Educational programs for rare disease families
Public awareness activities
Information sessions or webinars addressing patient needs

3. Quality of Life & Family Support

Programs improving daily living for rare disease patients
Community-based services
Initiatives addressing mental health, resilience, and well-being

4. Rare Disease Day & Advocacy Events

Local and national events that uplift patient voices
Activities that strengthen the rare disease advocacy landscape

Note:
This program does not support clinical research, investigator-initiated studies, or medical education grants. It is intended strictly for charitable, non-commercial purposes.

Eligibility

Applicants must be:

A 501(c)(3) nonprofit organization or equivalent international nonprofit
Focused on serving the rare disease community
Offering programs that align with Amicus’s mission and values

Organizations must also demonstrate:

A clear charitable purpose
Transparent program goals
Benefit to patients, caregivers, or advocacy communities

Amicus typically does not fund:

Individuals
Political or religious activities
For-profit entities
Capital campaigns
Promotional or product-related programs

Funding Amounts

Amicus does not publish standard award ranges.
Funding varies based on:

Program size and scope
Alignment with rare disease patient needs
Expected impact and reach
Budget justification

Historically, contributions support programmatic and community-focused initiatives, not general operating budgets.

Deadline

Applications are accepted year-round.

Organizations should submit requests 6–8 weeks before funding is needed to allow for internal review.

Geographic Focus

Amicus supports rare disease nonprofits in:

The United States (primary focus)
International communities where Amicus operates or supports patient populations

Programs must directly serve the rare disease community in the relevant region.

Application Process

Visit the Amicus Corporate Giving webpage
Review guidelines and confirm rare disease alignment
Complete the Corporate Giving request form
Provide:
- Organization information and nonprofit verification
- Program description and goals
- Target population and projected impact
- Detailed budget and funding amount requested
Amicus reviews applications on a rolling basis

Applicants are notified via email following review.

Why This Opportunity Is a Good Fit

Ideal for nonprofits that:

Serve individuals and families living with rare diseases
Offer education, advocacy, or support programs
Provide direct community services
Host awareness events or patient-centered initiatives

This opportunity is especially beneficial for patient advocacy groups seeking funding for programs, events, or outreach that improve the quality of life for rare disease communities.

Apply here: Link to Application